In the BioHarmony Drug Report Database

"Preview" Icon

Golodirsen

Vyondys (golodirsen) is an oligonucleotide pharmaceutical. Golodirsen was first approved as Vyondys on 2019-12-12. It is used to treat duchenne muscular dystrophy in the USA. Vyondys 53’s patents are valid until 2025-06-28 (FDA).

 

Trade Name

 

Vyondys
 

Common Name

 

golodirsen
 

ChEMBL ID

 

CHEMBL4297762
 

Indication

 

duchenne muscular dystrophy
 

Drug Class

 

Antisense oligonucleotides

Image (chem structure or protein)

Golodirsen structure rendering